Professor Clapham gained his degrees and PhD from Birkbeck College, University of London and has worked in the pharmaceutical industry for over 30 years. He started his career as a scientist with Beecham Pharmaceuticals (now GSK) and, from 2001, with AstraZeneca, first in Sweden then the UK. At AstraZeneca John was Senior Director of Bioscience providing project support, resource and strategy to the cardiometabolic disease area. John has extensive experience of project management, capability and technology development, line management and people development. He has held senior leadership roles in both operational and disease area strategy teams.